Hi HC42,
In this thread, (Post #: 6959698), I talked of mine profit.
This is based on avg qtly price - C1 cash cost.
It is a good way to compare different companies, but cannot be used to determine a dividend. My number excludes Overheads, Depn and Amortisation, exploration expense, tax expense, interest (rec or paid), debt repayment, sale of non core assets etc (you get the picture).
So I would be careful in using the figure of $429m to calculate a dividend.
Also, with all the studies going on, I would suspect that they will not pay out the max, they will conserve cash to pay for expansion.
If I had to hazard a guess, I would say a divi of 40c per share (unfranked) for the June half would not be unreasonable.
HT1
- Forums
- ASX - By Stock
- OZL
- june 2011 - quarterly review
june 2011 - quarterly review, page-21
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OZL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online